price
PT
AMEX · PTN
Palatin Technologies, Inc.
Healthcare · Biotechnology
$10.94
Down-$2.42 (-18.11%)
Updated Sep 16, 2026, 1:11 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 641.56M
- P/E ratio
- -4.99
- Dividend yield
- 0.00%
- 52-week range
- $7.21 – $23.78
- Volume
- 147.64K
- Avg. volume
- 1.78M
Price performance
PTN price history
1M range · 20 trading sessions · Daily adjusted prices
PTN closed at $10.94 after 20 trading sessions, up 4.09% for the selected period.
- Last close
- $10.94
- Period change
- +4.09%
- Period low
- $9.69
- Period high
- $13.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $13.07 | $13.37 | $10.77 | $10.94 | 147.64K |
| Sep 14, 2026 | $11.72 | $13.78 | $11.18 | $13.36 | 699.55K |
| Sep 11, 2026 | $11.82 | $12.57 | $11.40 | $11.80 | 20.61K |
| Sep 10, 2026 | $12.27 | $12.54 | $11.77 | $12.02 | 21.93K |
| Sep 9, 2026 | $12.28 | $12.87 | $11.7916 | $12.33 | 45.42K |
| Sep 8, 2026 | $12.62 | $13.33 | $11.77 | $12.68 | 138.09K |
| Sep 4, 2026 | $12.83 | $13.48 | $12.49 | $12.70 | 257.72K |
| Sep 3, 2026 | $12.82 | $14.00 | $12.34 | $13.08 | 534.54K |
| Sep 2, 2026 | $12.00 | $13.50 | $11.29 | $12.84 | 311.13K |
| Sep 1, 2026 | $9.63 | $11.82 | $9.175 | $11.54 | 149.15K |
| Aug 31, 2026 | $10.52 | $10.73 | $9.42 | $9.99 | 153.25K |
| Aug 28, 2026 | $10.5596 | $11.11 | $9.65 | $10.48 | 129.11K |
| Aug 27, 2026 | $10.09 | $10.49 | $9.55 | $10.49 | 62.19K |
| Aug 26, 2026 | $10.60 | $10.9299 | $9.26 | $10.47 | 58.52K |
| Aug 25, 2026 | $10.35 | $10.92 | $9.88 | $10.37 | 106.83K |
| Aug 24, 2026 | $9.69 | $10.16 | $9.69 | $10.16 | 1.79K |
| Aug 21, 2026 | $10.63 | $10.7493 | $9.69 | $9.69 | 4.5K |
| Aug 20, 2026 | $10.99 | $10.99 | $10.15 | $10.20 | 7.49K |
| Aug 19, 2026 | $10.40 | $10.9668 | $10.13 | $10.18 | 8.79K |
| Aug 18, 2026 | $10.66 | $11.13 | $10.27 | $10.51 | 22.45K |
Latest PTN news
The latest Smart Investors Daily articles mentioning PTN.
Stock researchResearch & News · SEC Filings
Loading stock research…